Global Skin Grafting Device Market

Global Skin Grafting Device Market

Global skin grafting device market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

Skin grafting is a type of surgery. During this procedure, providers take healthy skin from one part of the body and transplant it to cover damaged or missing skin. Within a few days, the grafted skin develops blood vessels and connects to the skin around it. Skin grafts cover wounds with severely damaged or missing skin to protect them from the environment, infections and excessive water and temperature loss.

Skin grafting devices are medical tools and equipments that are used in the process of skin grafting procedure where skin or a portion of skin is removed from one area of the body and transplanted to another area. Skin grafts are commonly performed to treat various medical conditions, including burns, chronic wounds, skin defects and certain dermatological disorders. The goal is to promote wound healing, reduce scarring and improve the function and appearance of the affected area.

Market Dynamics: Drivers

Increasing adoption of grafting devices for skin burns and wounds

The increasing adoption of grafting devices for skin burns and wounds is expected to drive the market over the forecast period. The prevalence of skin burns and chronic wounds continues to increase globally due to various factors such as accidents, trauma, surgical procedures and medical conditions. As a result, there is a growing need for skin grafting devices.

For instance, according to the World Health Organization (WHO), it is estimated that each year approximately 11 million people suffer from burn wounds, 180,000 of whom die because of such injuries. This increasing incidence of burns and wounds is expected to increase the adoption of these devices.

Ongoing advancements in skin grafting devices, including innovations in dermatomes, meshers, blades and other tools, enhance the efficiency and success of grafting procedures. Surgeons are likely to adopt these advanced devices for skin conditions like skin burns and wounds which results in better patient outcomes.

For instance, on June 15, 2021, Mallinckrodt plc cleared the U.S. Food and Drug Administration (FDA) approval of StrataGraft (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen – dsat) for the treatment of adults with thermal burns containing intact dermal elements for which surgical intervention is clinically indicated (deep partial-thickness burns).

Further, the increasing prevalence of various chronic skin conditions, rising FDA approvals for advanced grafting devices, increasing awareness about the advantages of skin grafting devices and increasing advancements in the development of novel instruments and tools are the factors expected to drive the market over the forecast period.

Restraints

Factors such as the high cost of devices and procedures, limited availability of donor tissue, complications associated with the various devices, unmet needs and uncertainties regarding the devices are the factors expected to hamper the market.

For more details on this report - Request for Sample

Segment Analysis

The global skin grafting device market is segmented based on graft type, graft thickness, device type, application, end-user and region.

The skin grafting knives segment accounted for approximately 36.7% of the skin grafting device market share

The skin grafting knives segment is expected to hold the largest market share over the forecast period. Skin grafting knives are considered essential tools that are used in skin grafting procedures. These devices are specifically designed for precise cutting during the harvesting of skin grafts from the donor site. The knives are crucial for ensuring the grafts are of the desired thickness and size.

Skin grafting knives are designed to provide surgeons with precise control over the cutting process. This is crucial to harvest skin grafts of the appropriate thickness, which may vary depending on the specific requirements of the recipient site. Depending on the design and material, skin grafting knives may be single-use or reusable. Single-use knives reduce the risk of infection and ensure sterility, while reusable knives require thorough cleaning and sterilization between uses.

The handle of a skin grafting knife is designed to provide a comfortable and secure grip for the surgeon, allowing for precise and controlled movements during the grafting process. Some skin grafting knives may incorporate safety features to minimize the risk of accidental injuries during use. These features may increase the demand for skin grafting knives.

Geographical Analysis

North America accounted for approximately 41.3% of the market share

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing demand for skin grafting devices in the region. North America especially the United States is very well-known for its strong presence of major players such as pharmaceutical companies and medical devices, which especially focus on introducing more advanced skin grafting devices.

For instance, on June 07, 2023, AVITA Medical, Inc. released that the U.S. Food and Drug Administration (FDA) has approved its premarket approval (PMA) supplement for the use of its RECELL System to treat full-thickness skin defects. The RECELL System is designed to be used at the point of care alone or in combination with autografts depending on the depth of the burn injury or in combination with meshed autographs for full-thickness skin defects.

In addition, there is an increasing demand for skin grafting devices due to the increasing incidence of skin burns, wounds and others in the region. For instance, according to the National Institute of Health, approximately 486,000 patients require treatment for burns, and 40,000 require hospitalization within the United States each year.

Competitive Landscape

The major global players in the skin grafting device market include Zimmer Biomet, B. Braun Melsungen AG, Integra LifeSciences, Exsurco Medical, Inc., Rudolf Storz GmbH, De Soutter Medical Limited, L&R Group, AVITA Medical, Inc., Stratatech Corporation and Sklar Surgical Instruments among others.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global skin grafting device market. The coronavirus disease 2019 (COVID-19) pandemic led to a significant disruption in elective surgeries as healthcare systems worldwide focused on managing COVID-19 cases and conserving resources. Non-essential procedures, including some skin grafting surgeries, were postponed or canceled, impacting the demand for related devices.

Market Segmentation

By Graft Type
• Autograft (Isograft)
• Allograft (Homograft)
• Xenograft (Heterograft)

By Graft Thickness
• Split Thickness
• Full Thickness
• Composite

By Device Type
• Skin Graft Meshers
• Skin Grafting Knives
• Dermatome Blades
• Others

By Application
• Deep Skin Burns
• Open Wounds
• Pressure Injuries
• Bed Sores
• Others

By End-User
• Hospitals
• Specialty Clinics
• Dermatology Clinics
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Why Purchase the Report?
• To visualize the global skin grafting device market segmentation based on graft type, graft thickness, device type, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of skin grafting device market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global skin grafting device market report would provide approximately 77 tables, 81 figures and 187 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies